117 related articles for article (PubMed ID: 6924684)
21. Plasma prekallikrein, factor XII, antithrombin III, C1(-)-inhibitor and alpha 2-macroglobulin in critically ill patients with suspected disseminated intravascular coagulation (DIC).
Lämmle B; Tran TH; Ritz R; Duckert F
Am J Clin Pathol; 1984 Oct; 82(4):396-404. PubMed ID: 6206713
[TBL] [Abstract][Full Text] [Related]
22. Determination of prekallikrein in plasma by means of a chromogenic tripeptide substrate for plasma kallikrein.
Friberger P; Eriksson E; Gustavsson S; Claeson G
Adv Exp Med Biol; 1979; 120A():67-82. PubMed ID: 40406
[TBL] [Abstract][Full Text] [Related]
23. Studies on components of the plasma kallikrein-kinin system in plasma samples from normal individuals and patients with septic shock.
Aasen AO; Erichsen NS; Gallimore MJ; Amundsen E
Adv Shock Res; 1980; 4():1-10. PubMed ID: 6172027
[TBL] [Abstract][Full Text] [Related]
24. Assay of Fletcher factor (plasma prekallikrein) using an artificial clotting reagent and a modified chromogenic assay.
Soulier JP; Gozin D
Thromb Haemost; 1979 Aug; 42(2):538-47. PubMed ID: 505362
[TBL] [Abstract][Full Text] [Related]
25. Septic shock in the rat: activation of plasma proteolytic systems and effects of a kallikrein inhibitor/bradykinin antagonist (S-2441).
Högström H; Claeson G; Larsson-Backström C; Lundberg D; Wenngren E; Haglund U
Acta Chir Scand; 1987 Mar; 153(3):161-4. PubMed ID: 3300117
[TBL] [Abstract][Full Text] [Related]
26. Plasma prekallikrein: quantitative determination by direct activation with Hageman factor fragment (beta-XIIa).
Alving BM; Tankersley DL; Mason BL
J Lab Clin Med; 1983 Feb; 101(2):226-41. PubMed ID: 6549773
[TBL] [Abstract][Full Text] [Related]
27. Amidolytic prekallikrein (PK) assay: unsuitability of Cephotest as an activator.
Lämmle B; Lohri A; Tran TH; Czendlik C
Thromb Haemost; 1984 Apr; 51(2):294. PubMed ID: 6564798
[No Abstract] [Full Text] [Related]
28. [Plasma prekallikrein level in pregnancy toxemia].
Tinneberg HR; Anger H; Woelki HW
Dtsch Med Wochenschr; 1983 Mar; 108(9):358. PubMed ID: 6549985
[No Abstract] [Full Text] [Related]
29. Prekallikrein deficiency in a kindred with kininogen deficiency and Fitzgerald trait clotting defect. Evidence that high molecular weight kininogen and prekallikrein exist as a complex in normal human plasma.
Donaldson VH; Kleniewski J; Saito H; Sayed JK
J Clin Invest; 1977 Sep; 60(3):571-83. PubMed ID: 893663
[TBL] [Abstract][Full Text] [Related]
30. Plasma prekallikrein activity in patients with total hip arthroplasty.
Hoffmann JJ; Kortmann JH
Thromb Haemost; 1987 Dec; 58(4):1040-2. PubMed ID: 3445224
[TBL] [Abstract][Full Text] [Related]
31. Plasma prekallikrein, kallikrein inhibitors, kininogen and lipids during gemfibrozil treatment in type II dyslipidaemia.
Torstila I; Kaukola S; Manninen V; Virtamo J; Mälkönen M
Acta Med Scand Suppl; 1982; 668():123-9. PubMed ID: 6188330
[TBL] [Abstract][Full Text] [Related]
32. New congenital deficiency of high molecular weight kininogen and prekallikrein (Fitzgerald trait). Study of response to DDAVP and venous occlusion.
Vicente V; Alberca I; Gonzalez R; Alegre A; Redondo C; Moro J
Haematologia (Budap); 1986; 19(1):41-8. PubMed ID: 3636267
[TBL] [Abstract][Full Text] [Related]
33. Tachibana trait: human high molecular weight kininogen deficiency with diminished levels of prekallikrein and low molecular weight kininogen.
Nakamura K; Iijima K; Fukuda C; Kadowaki H; Ikoma H; Oh-ishi S; Uchida Y; Katori M
Nihon Ketsueki Gakkai Zasshi; 1985 Sep; 48(6):1473-9. PubMed ID: 3853954
[No Abstract] [Full Text] [Related]
34. Factor XII-independent cleavage of high-molecular-weight kininogen by prekallikrein and inhibition by C1 inhibitor.
Joseph K; Tholanikunnel BG; Kaplan AP
J Allergy Clin Immunol; 2009 Jul; 124(1):143-9. PubMed ID: 19342086
[TBL] [Abstract][Full Text] [Related]
35. [Fundamental studies on the management of disseminated intravascular coagulation (DIC) with antithrombin III (AT-III) concentrate].
Gotoh K
Nihon Sanka Fujinka Gakkai Zasshi; 1985 Apr; 37(4):571-80. PubMed ID: 3989338
[TBL] [Abstract][Full Text] [Related]
36. Hageman factor-dependent pathways: mechanism of initiation and bradykinin formation.
Kaplan AP
Fed Proc; 1983 Nov; 42(14):3123-7. PubMed ID: 6556144
[TBL] [Abstract][Full Text] [Related]
37. Methods for determination of prekallikrein in plasma, glandular kallikrein and urokinase.
Claeson G; Friberger P; Knös M; Eriksson E
Haemostasis; 1978; 7(2-3):76-8. PubMed ID: 26629
[TBL] [Abstract][Full Text] [Related]
38. [A study of coagulation contact factors in hereditary angioneurotic oedema (author's transl)].
Soulier JP; Gozin D; Ollier-Hartmann MP; Hartmann L
Nouv Presse Med; 1981 May; 10(20):1627-31. PubMed ID: 6166918
[TBL] [Abstract][Full Text] [Related]
39. Studies on blood coagulation-fibrinolysis system regarding kallikrein-kinin system in the utero-placental circulation during normal pregnancy, labor and puerperium.
Mutoh S; Kobayashi M; Hirata J; Itoh N; Maki M; Komatsu Y; Yoshida A; Sasa H; Kuroda K; Kikuchi Y
Agents Actions Suppl; 1992; 38 ( Pt 2)():320-9. PubMed ID: 1462839
[TBL] [Abstract][Full Text] [Related]
40. Description and evaluation of a new chromogenic substrate assay kit for the determination of prekallikrein in human plasma.
Friberger P; Gallimore MJ
Adv Exp Med Biol; 1986; 198 Pt B():543-8. PubMed ID: 3643742
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
